Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Oxford BioMedica (OXBDF) Income after Taxes data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$175.28M |
|
$90.36M |
|
$133.90M |
|
$309.18M |
|
$74.65M |
|
$133.14M |
|
$144.64M |
|
$219.29M |
|
$89.89M |
|
$52.04M |
|
$89.89M |
|
105.31M |
|
| Cash Flow Statement Financials | |
$-49.47M |
|
$9.20M |
|
$12.35M |
|
$130.90M |
|
$102.75M |
|
$-28.15M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|